/Passle/5e8c58ad3dccd208784b45a3/MediaLibrary/Images/2024-10-15-19-53-27-360-670ec837dd71ccaa0996a993.png)
On September 10, 2025 the Department of Defense (DoD) issued its final rule (Rule) amending the Defense Federal Acquisition Regulation...
A Fresh Take
Insights on US legal developments
Significant Chinese investment in its biotechnology industry has resulted in a shift in the biopharma licensing market over the last five...
The BIOSECURE Act, first introduced in Congress last year, has now been reintroduced for inclusion in Senate’s draft of the annual...
Trends converging in recent months have the potential to reshape the operating environment for fintechs, digital asset and payments...
On September 5, 2025, President Trump issued an Executive Order titled “Implementing the United States-Japan Agreement” (the “EO”). The...
The US Commerce Department’s Bureau of Industry and Security (BIS) published a new rule, effective September 2, 2025, that significantly...
On September 5, 2025, the Federal Trade Commission (FTC) announced its first enforcement action under the Integrity, Notification, and...
On September 4, 2025, the Federal Trade Commission (“FTC”) ordered Gateway Services, Inc.—the largest pet cremation company in the United...
On August 29, 2025, in a 7-4 en banc decision, the U.S. Court of Appeals for the Federal Circuit (Federal Circuit) affirmed a lower court...
The U.S. Court of Appeals for the Sixth Circuit recently issued a decision reaffirming key elements of attorney-client privilege and...
Litigants try to use 28 U.S.C. § 1782 applications to get tactical advantages in transnational litigation all the time. After all, the...
As big pharmas and other commercial-stage biopharma and biotech companies grapple with the reality of patent cliffs on the horizon, which...